Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 October 2005

Interleukin-1α enhances IL-8 secretion through p38 mitogen-activated protein kinase and reactive oxygen species signaling in human pancreatic cancer cells

Hirozumi Sawai, Hitoshi Funahashi, Yuji Okada, Yoichi Matsuo, Yoichi Matsuo, Masaki Sakamoto, Minoru Yamamoto, Hiromitsu Takeyama, Tadao Manabe

Med Sci Monit 2005; 11(10): BR343-350 :: ID: 430275

Abstract

Background:Interleukin (IL)-1α plays an important role in modulating the expression of various growth factors and angiogenic factors in tumor cells. In here, we investigated effect of IL-1α on IL-8 secretion in human pancreatic cancer cells and underlying signal transduction pathways.Material/Methods:IL-8 expression and secretion by pancreatic cancer cells was measured by Western blot and enzyme-linked immunosorbent assay (ELISA), respectively. Activation of extracellular signal regulated kinases-1/2 (ERK-1/2), p38 mitogen-activated protein kinase (MAPK), c-jun aminoterminal kinase, Akt, and nuclear factor-κB (NF-κB) was determined by Western blot. Involvement of reactive oxygen species (ROS) were examined by measuring the H[sub]2[/sub]O[sub]2[/sub]. Activity of activator factor-1 (AP-1) and NF-κB was examined by electrophoretic mobility sift assay (EMSA). Proliferation of human umbilical vein endothelial cells (HUVECs) was determined by the 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide dye reduction method and cell count.Results:IL-1α modulated IL-8 secretion and induced activation of ERK-1/2 and p38 MAPK. Specific inhibitors for MEK-1 and p38 MAPK suppressed IL-8 secretion. IL-1α also induced production of ROS. Exogenous H[sub]2[/sub]O[sub]2[/sub] enhanced IL-8 secretion and N-acetyl cysteine (NAC) prevented IL-1α-induced ROS production and IL-8 secretion. EMSA confirmed that IL-1α increased DNA-binding activity of AP-1 and NF-κB. Inhibitors and ROS scavenger studies revealed that upstream signalings for AP-1 and NF-κB were MAPK and ROS, respectively. Conditioned media from pancreatic cancer cells pretreated with IL-1α remarkably stimulated in vitro HUVECs growth.Conclusions:These results suggest that MAPK/AP-1 and ROS/NF-κB signaling pathways are involved in IL-1α -induced IL-8 secretion and that these paracrine signaling pathways enhance endothelial cell proliferation.

Keywords: Electrophoretic Mobility Shift Assay, Culture Media, Conditioned, Blotting, Western, Enzyme-Linked Immunosorbent Assay, Interleukin-1 - physiology, Interleukin-8 - secretion, Pancreatic Neoplasms - pathology, Signal Transduction - physiology, Transcription Factor AP-1 - metabolism, Tumor Cells, Cultured, p38 Mitogen-Activated Protein Kinases - metabolism

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750